Therapeutic efficacy and safety of combined <i>BRAF</i> and MEK inhibition in patients with malignant melanoma: a meta-analysis.

Onco Targets Ther · 2017 · PMC5692200 · PMID 29180872

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

However, because the number of included studies was only eight, the funnel plots may not be significant.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.